Exploration of Active Substances and Its Potential Mechanism of Gancao Fuzi Decoction on Inflammatory Based on Metabolomics and Network Pharmacology
Rapid Communications in Mass Spectrometry · 2025
DOI: 10.1002/rcm.10007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rapid Communications in Mass Spectrometry, 2025. Verfasst von Wei Geng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shandong FuPai Pharmaceutical Co. Ltd, Jinan, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Anti-Inflammatory Agents, Inflammation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Key Research and Development Project, The China Agriculture Research System of MOF and MARA, Shandong Province Taishan Scholar Program.
Abstract (Originalsprache)
Gancao Fuzi decoction (GCFZT) is a traditional Chinese formula, which has been commonly used in clinical practice to treat inflammatory diseases. However, the active substance of GCFZT in the treatment of inflammation is not fully clarified. In this study, we used orthogonal experiments to design different GCFZT formulations, resulting in a total of 16 GCFZT formulations. Subsequently, UPLC‐Q‐TOF‐MS/MS was used to analyze the chemical composition of different formulations, and the anti‐inflammatory activity differences of these formulations were evaluated through an LPS‐induced RAW264.7 inflammatory cell model. Combined with machine learning algorithms such as PLS‐DA and RF, four main active substances in GCFZT were screened. Finally, network pharmacology techniques were used to investigate the potential anti‐inflammatory mechanisms of these main active substances, and the results showed that GCFZT mainly regulates the expression of core targets such as ALOX5, NFKB1, and TLR4 through main active substances such as chlorogenic acid, riboflavin, and formononetin, thereby affecting the NF kappa B signaling pathway, the Toll‐like receptor signaling pathway, and the Th17 cell differentiation. This study provides a reference for the anti‐inflammatory mechanism of GCFZT and a scientific basis for its clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shandong FuPai Pharmaceutical Co. Ltd, Jinan, China.
- Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jinan, China.
- Shandong University of Traditional Chinese Medicine, Jinan, China.
- Key Laboratory for Applied Technology of Sophisticated Analytical Instruments of Shandong Province, Shandong Analysis and Test Center, Qilu University of Technology (Shandong Academy of Sciences), Jinan, China.
- Department of Food Science and Technology, Faculty of Agriculture, University of Ruhuna, Kamburupitiya, Sri Lanka.
ORCID-Profile: Xiao Wang
Förderung
- National Key Research and Development Project
- The China Agriculture Research System of MOF and MARA
- Shandong Province Taishan Scholar Program
Zitieren
APA
Geng, W., Liu, S., Dong, H., Arachchige, B. N. P., Qi, D., & Wang, X. (2025). Exploration of Active Substances and Its Potential Mechanism of Gancao Fuzi Decoction on Inflammatory Based on Metabolomics and Network Pharmacology. Rapid Communications in Mass Spectrometry. https://doi.org/10.1002/rcm.10007
Vancouver
Geng W, Liu S, Dong H, Arachchige BNP, Qi D, Wang X. Exploration of Active Substances and Its Potential Mechanism of Gancao Fuzi Decoction on Inflammatory Based on Metabolomics and Network Pharmacology. Rapid Communications in Mass Spectrometry. 2025. doi:10.1002/rcm.10007
BibTeX
@article{Geng2025,
author = {Geng, Wei and Liu, Shuang and Dong, Hongjing and Arachchige, Buddhika Niroshie Perumpuli and Qi, Dongmei and Wang, Xiao},
title = {Exploration of Active Substances and Its Potential Mechanism of Gancao Fuzi Decoction on Inflammatory Based on Metabolomics and Network Pharmacology},
journal = {Rapid Communications in Mass Spectrometry},
year = {2025},
doi = {10.1002/rcm.10007}
}
EUVIMED